OncLive - Clinical Oncology News, Cancer Expert Insights
OncLive - Clinical Oncology News, Cancer Expert Insights
Spotlight
OncClub: Join the Chat on Trending Trials in CancerComplimentary print subscription for home or office deliveryIn-person and virtual events just for HCPsLively expert panel discussions featuring peer-to-peer exchangesSubscribe to our eNewsletter for breaking news and curated content
Specialty
View MoreBreast CancerCAR T-cell TherapyChronic Lymphocytic LeukemiaGastrointestinal CancerGenitourinary CancersGynecologic OncologyImmuno-OncologyLung CancerMelanoma & Skin CancerMultiple MyelomaUrothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
Rare Cancer Series
Media
Insights
Medical World News
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Thoracic Night Live
Conferences
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live
Oncology Fellows
Supplements And Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Subscribe
eNewsletter
Print Subscription
  • Advertise
  • About OncLive
  • Editorial Board
  • CancerNetwork.com
  • CGTlive.com
  • CureToday.com
  • OncNursingNews.com
  • TargetedOnc.com
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information

© 2022 MJH Life Sciences and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

Spotlight
  • OncClub: Join the Chat on Trending Trials in Cancer
  • Complimentary print subscription for home or office delivery
  • In-person and virtual events just for HCPs
  • Lively expert panel discussions featuring peer-to-peer exchanges
  • Subscribe to our eNewsletter for breaking news and curated content
SpecialtySee All >
  • Breast Cancer
  • CAR T-cell Therapy
  • Chronic Lymphocytic Leukemia
  • Gastrointestinal Cancer
  • Genitourinary Cancers
  • Gynecologic Oncology
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Multiple Myeloma
  • Urothelial Cancer
OncLive SOSS
  • Advertise
  • About OncLive
  • Editorial Board
  • CancerNetwork.com
  • CGTlive.com
  • CureToday.com
  • OncNursingNews.com
  • TargetedOnc.com
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
  • MJHLS Brand Logo

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

Advanced Ovarian Cancer: Optimizing Therapy Based on Current Data

EP. 1: Neoadjuvant Chemo VS Cytoreductive Surgery in OC

November 28th 2018

EP. 2: Recommendations for Molecular Testing in Advanced OC

November 28th 2018

EP. 3: Upfront Systemic Therapy in Addition to Chemo?

November 28th 2018

EP. 4: Highly Anticipated Data from the SOLO-1 Trial

November 28th 2018

EP. 5: The Evolution of Single-Agent PARP Inhibitors

November 28th 2018

EP. 6: PARP Combinations: The Future

November 28th 2018

EP. 7: Role of HIPEC in Newly Diagnosed Advanced Peritoneal Cancer

November 28th 2018

EP. 8: Factors in Choice of Treatment for Recurrent Ovarian Cancer

November 28th 2018

EP. 9: Maintenance Therapy for Recurrent Advanced Ovarian Cancer

November 28th 2018

EP. 10: PARP Inhibitors: Which One Should We Use?

November 28th 2018

EP. 11: ADC in Platinum-Resistant Ovarian Cancer

November 28th 2018

EP. 12: The Role of I-O in Platinum-Resistant Recurrent OC

November 28th 2018

EP. 13: Novel Agents and the Future Treatment of Ovarian Cancer

November 28th 2018